HIMS - Is Hims & Hers Health Stock a Buy?
2024-05-13 04:37:00 ET
Telehealth company Hims & Hers Health (NYSE: HIMS) found itself immersed in controversy recently after some polarizing social media posts by the company's CEO sparked debate. The stock took a bit of a hit as a result Then the company released first-quarter earnings amid the uproar, giving bulls a lot to cheer about.
While it's often a bad idea for a company to go anywhere near political discussions, there are enough reasons the business is doing well to help overcome its recent stumble and become an excellent long-term investment.
Here are six potential reasons to buy Hims & Hers stock today.
For further details see:
Is Hims & Hers Health Stock a Buy?